Differences in gut microbiota between Dutch and South-Asian Surinamese: potential implications for type 2 diabetes mellitus.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 Feb 2024
26 Feb 2024
Historique:
received:
08
10
2023
accepted:
16
02
2024
medline:
26
2
2024
pubmed:
26
2
2024
entrez:
25
2
2024
Statut:
epublish
Résumé
Gut microbiota, or the collection of diverse microorganisms in a specific ecological niche, are known to significantly impact human health. Decreased gut microbiota production of short-chain fatty acids (SCFAs) has been implicated in type 2 diabetes mellitus (T2DM) disease progression. Most microbiome studies focus on ethnic majorities. This study aims to understand how the microbiome differs between an ethnic majority (the Dutch) and minority (the South-Asian Surinamese (SAS)) group with a lower and higher prevalence of T2DM, respectively. Microbiome data from the Healthy Life in an Urban Setting (HELIUS) cohort were used. Two age- and gender-matched groups were compared: the Dutch (n = 41) and SAS (n = 43). Microbial community compositions were generated via DADA2. Metrics of microbial diversity and similarity between groups were computed. Biomarker analyses were performed to determine discriminating taxa. Bacterial co-occurrence networks were constructed to examine ecological patterns. A tight microbiota cluster was observed in the Dutch women, which overlapped with some of the SAS microbiota. The Dutch gut contained a more interconnected microbial ecology, whereas the SAS network was dispersed, i.e., contained fewer inter-taxonomic correlational relationships. Bacteroides caccae, Butyricicoccus, Alistipes putredinis, Coprococcus comes, Odoribacter splanchnicus, and Lachnospira were enriched in the Dutch gut. Haemophilus, Bifidobacterium, and Anaerostipes hadrus discriminated the SAS gut. All but Lachnospira and certain strains of Haemophilus are known to produce SCFAs. The Dutch gut microbiome was distinguished from the SAS by diverse, differentially abundant SCFA-producing taxa with significant cooperation. The dynamic ecology observed in the Dutch was not detected in the SAS. Among several potential gut microbial biomarkers, Haemophilus parainfluenzae likely best characterizes the ethnic minority group, which is more predisposed to T2DM. The higher prevalence of T2DM in the SAS may be associated with the gut dysbiosis observed.
Identifiants
pubmed: 38403716
doi: 10.1038/s41598-024-54769-4
pii: 10.1038/s41598-024-54769-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4585Subventions
Organisme : ZONMW-VICI
ID : 09150182010020
Informations de copyright
© 2024. The Author(s).
Références
Berg, G. et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome 8, 103 (2020).
pubmed: 32605663
pmcid: 7329523
Münger, E., Montiel-Castro, A. J., Langhans, W. & Pacheco-López, G. Reciprocal interactions between gut microbiota and host social behavior. Front. Integr. Neurosci. 12, (2018).
Ogunrinola, G. A., Oyewale, J. O., Oshamika, O. O. & Olasehinde, G. I. The human microbiome and its impacts on health. Int. J. Microbiol. 2020, e8045646 (2020).
Hooks, K. B. & O’Malley, M. A. Dysbiosis and its discontents. mBio 8, e01492-e1517 (2017).
pubmed: 29018121
pmcid: 5635691
Foster, J. A. & McVey Neufeld, K.-A. Gut–brain axis: How the microbiome influences anxiety and depression. Trends Neurosci. 36, 305–312 (2013).
pubmed: 23384445
Scher, J. U. & Abramson, S. B. The microbiome and rheumatoid arthritis. Nat. Rev. Rheumatol. 7, 569–578 (2011).
pubmed: 21862983
pmcid: 3275101
Wong, S. H. & Yu, J. Gut microbiota in colorectal cancer: Mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 16, 690–704 (2019).
pubmed: 31554963
Khan, I. et al. Alteration of gut microbiota in inflammatory bowel disease (IBD): Cause or consequence? IBD treatment targeting the gut microbiome. Pathogens 8, 126 (2019).
pubmed: 31412603
pmcid: 6789542
Romano, S. et al. Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 7, 1–13 (2021).
Kang, D.-W. et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study. Microbiome 5, 10 (2017).
pubmed: 28122648
pmcid: 5264285
Mathee, K., Cickovski, T., Deoraj, A., Stollstorff, M. & Narasimhan, G. The gut microbiome and neuropsychiatric disorders: Implications for attention deficit hyperactivity disorder (ADHD). J. Med. Microbiol. 69, 14–24 (2020).
pubmed: 31821133
Devaraj, S., Hemarajata, P. & Versalovic, J. The human gut microbiome and body metabolism: Implications for obesity and diabetes. Clin. Chem. 59, 617–628 (2013).
pubmed: 23401286
pmcid: 3974587
Bielka, W., Przezak, A. & Pawlik, A. The role of the gut microbiota in the pathogenesis of diabetes. Int. J. Mol. Sci. 23, 480 (2022).
pubmed: 35008906
pmcid: 8745411
Vals-Delgado, C. et al. An altered microbiota pattern precedes Type 2 diabetes mellitus development: From the CORDIOPREV study. J. Adv. Res. 35, 99–108 (2022).
pubmed: 35024196
Fang, Y. et al. Characteristics of the gut microbiota and metabolism in patients with latent autoimmune diabetes in adults: A case-control study. Diabetes Care 44, 2738–2746 (2021).
pubmed: 34620611
pmcid: 8669532
Zhou, W. et al. Longitudinal multi-omics of host–microbe dynamics in prediabetes. Nature 569, 663–671 (2019).
pubmed: 31142858
pmcid: 6666404
National Diabetes Statistics Report | Diabetes | CDC. https://www.cdc.gov/diabetes/data/statistics-report/index.html (2022).
International Diabetes Federation (2019) IDF Diabetes Atlas: Ninth edition 2019. Available from https://diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf . Accessed Sept 7th, 2023.
Agyemang, C., van der Linden, E. L. & Bennet, L. Type 2 diabetes burden among migrants in Europe: Unravelling the causal pathways. Diabetologia 64, 2665–2675 (2021).
pubmed: 34657183
pmcid: 8563673
DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers 1, 15019 (2015).
pubmed: 27189025
Cui, J. et al. Butyrate-producing bacteria and insulin homeostasis: The microbiome and insulin longitudinal evaluation study (MILES). Diabetes 71, 2438–2446 (2022).
pubmed: 35972231
pmcid: 9630078
Gurung, M. et al. Role of gut microbiota in type 2 diabetes pathophysiology. eBioMedicine 51, (2020).
Letchumanan, G. et al. Gut microbiota composition in prediabetes and newly diagnosed type 2 diabetes: A systematic review of observational studies. Front. Cell. Infect. Microbiol. 12, (2022).
Guo, Z., Pan, J., Zhu, H. & Chen, Z.-Y. Metabolites of gut microbiota and possible implication in development of diabetes mellitus. J. Agric. Food Chem. 70, 5945–5960 (2022).
pubmed: 35549332
Sanna, S. et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat. Genet. 51, 600–605 (2019).
pubmed: 30778224
pmcid: 6441384
Morrison, D. J. & Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7, 189–200 (2016).
pubmed: 26963409
pmcid: 4939913
Blaak, E. et al. Short chain fatty acids in human gut and metabolic health. Benef. Microbes 11, 411–455 (2020).
McNelis, J. C. et al. GPR43 potentiates β-cell function in obesity. Diabetes 64, 3203–3217 (2015).
pubmed: 26023106
pmcid: 4542437
Priyadarshini, M. et al. An acetate-specific GPCR, FFAR2, regulates insulin secretion. Mol. Endocrinol. 29, 1055–1066 (2015).
pubmed: 26075576
pmcid: 4484778
Reddy, M. A. et al. Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA. Diabetes 63, 4249–4261 (2014).
pubmed: 25008173
pmcid: 4238007
Pingitore, A. et al. The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes. Metab. 19, 257–265 (2017).
pubmed: 27761989
Canfora, E. E. et al. Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: A randomized crossover trial. Sci. Rep. 7, 2360 (2017).
pubmed: 28539646
pmcid: 5443817
van der Beek, C. M. et al. Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. Clin. Sci. 130, 2073–2082 (2016).
Freeland, K. R. & Wolever, T. M. S. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. Br. J. Nutr. 103, 460–466 (2010).
pubmed: 19818198
Louis, P. & Flint, H. J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29–41 (2017).
pubmed: 27928878
Gaulke, C. A. & Sharpton, T. J. The influence of ethnicity and geography on human gut microbiome composition. Nat. Med. 24, 1495–1496 (2018).
pubmed: 30275567
Deschasaux, M. et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat. Med. 24, 1526–1531 (2018).
pubmed: 30150717
Gacesa, R. et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732–739 (2022).
pubmed: 35418674
Snijder, M. B. et al. Cohort profile: The healthy life in an urban setting (HELIUS) study in Amsterdam, The Netherlands. BMJ Open 7, e017873 (2017).
pubmed: 29247091
pmcid: 5736025
Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
pubmed: 27214047
pmcid: 4927377
Nayman, E. I. et al. Microbiome depiction through user-adapted bioinformatic pipelines and parameters. J. Med. Microbiol. 72, 001756 (2023).
Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2013).
pubmed: 23193283
Neu, A. T., Allen, E. E. & Roy, K. Defining and quantifying the core microbiome: Challenges and prospects. Proc. Natl. Acad. Sci. 118, e2104429118 (2021).
pubmed: 34862327
pmcid: 8713806
Pearson, K. L. I. I. I. On lines and planes of closest fit to systems of points in space. Lond. Edinburgh Dublin Philos. Mag. J. Sci. 2, 559–572 (1901).
Bray, J. R. & Curtis, J. T. An ordination of the upland forest communities of southern Wisconsin. Ecol. Monogr. 27, 325–349 (1957).
Anderson, M. J. Permutational multivariate analysis of variance (PERMANOVA). in Wiley StatsRef: Statistics Reference Online 1–15 (John Wiley & Sons, Ltd, 2017). https://doi.org/10.1002/9781118445112.stat07841 .
Chao, A. Nonparametric estimation of the number of classes in a population. Scand. J. Stat. 11, 265–270 (1984).
Shannon, C. E. A mathematical theory of communication. Bell Syst. Tech. J. 27, 379–423 (1948).
Fisher, R. A., Corbet, A. S. & Williams, C. B. The relation between the number of species and the number of individuals in a random sample of an animal population. J. Anim. Ecol. 12, 42–58 (1943).
Simpson, E. H. Measurement of diversity. Nature 163, 688–688 (1949).
Lozupone, C. & Knight, R. UniFrac: A new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 8228–8235 (2005).
pubmed: 16332807
pmcid: 1317376
Lozupone, C., Lladser, M. E., Knights, D., Stombaugh, J. & Knight, R. UniFrac: An effective distance metric for microbial community comparison. ISME J. 5, 169–172 (2011).
pubmed: 20827291
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
pubmed: 21702898
pmcid: 3218848
Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
pubmed: 20979621
pmcid: 3218662
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281
pmcid: 4302049
Schoch, C. L. et al. NCBI Taxonomy: A comprehensive update on curation, resources and tools. Database (Oxford) 2020, baaa062 (2020).
Faust, K. et al. Microbial co-occurrence relationships in the human microbiome. PLOS Comput. Biol. 8, e1002606 (2012).
pubmed: 22807668
pmcid: 3395616
Fernandez, M., Riveros, J. D., Campos, M., Mathee, K. & Narasimhan, G. Microbial ‘social networks’. BMC Genomics 16, S6 (2015).
pubmed: 26576770
pmcid: 4652466
Friedman, J. & Alm, E. J. Inferring correlation networks from genomic survey data. PLOS Comput. Biol. 8, e1002687 (2012).
pubmed: 23028285
pmcid: 3447976
Fruchterman, T. M. J. & Reingold, E. M. Graph drawing by force-directed placement. Softw. Pract. Exp. 21, 1129–1164 (1991).
Nagpal, R. et al. Gut microbiome and aging: Physiological and mechanistic insights. Nutr. Healthy Aging 4, 267–285 (2018).
pubmed: 29951588
pmcid: 6004897
Kim, Y. S., Unno, T., Kim, B.-Y. & Park, M.-S. Sex differences in gut microbiota. World J. Mens. Health 38, 48–60 (2020).
pubmed: 30929328
Snijder, M. B. et al. Case finding and medical treatment of type 2 diabetes among different ethnic minority groups: The HELIUS study. J. Diabetes Res. 2017, 9896849 (2017).
pubmed: 28154830
pmcid: 5244015
Willis, A. D. Rarefaction, Alpha Diversity, and Statistics. Front. Microbiol. 10, (2019).
Janda, J. M. & Abbott, S. L. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: Pluses, perils, and pitfalls. J. Clin. Microbiol. 45, 2761–2764 (2007).
pubmed: 17626177
pmcid: 2045242
Nearing, J. T. et al. Microbiome differential abundance methods produce different results across 38 datasets. Nat. Commun. 13, 342 (2022).
pubmed: 35039521
pmcid: 8763921
Cickovski, T., Aguiar-Pulido, V. & Narasimhan, G. MATria: A unified centrality algorithm. BMC Bioinf. 20, 278 (2019).
Freeman, L. C. Centrality in social networks conceptual clarification. Soc. Netw. 1, 215–239 (1978).
Frey, B. J. & Dueck, D. Clustering by passing messages between data points. Science 315, 972–976 (2007).
pubmed: 17218491
Belenguer, A. et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl. Environ. Microbiol. 72, 3593–3599 (2006).
pubmed: 16672507
pmcid: 1472403
Duncan, S. H., Louis, P. & Flint, H. J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70, 5810–5817 (2004).
pubmed: 15466518
pmcid: 522113
Lee, J.-Y. et al. Anaerostipes hominis sp. nov., a novel butyrate-producing bacteria isolated from faeces of a patient with Crohn’s disease. Int. J. Syst. Evol. Microbiol. 71, 1 (2021).
Sato, T. et al. Isolation of lactate-utilizing butyrate-producing bacteria from human feces and in vivo administration of Anaerostipes caccae strain L2 and galacto-oligosaccharides in a rat model. FEMS Microbiol. Ecol. 66, 528–536 (2008).
pubmed: 18554304
Schwiertz, A. et al. Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces. Syst. Appl. Microbiol. 25, 46–51 (2002).
López-López, N. et al. Haemophilus influenzae glucose catabolism leading to production of the immunometabolite acetate has a key contribution to the host airway-pathogen interplay. ACS Infect. Dis. 6, 406–421 (2020).
pubmed: 31933358
Huart, J. et al. Gut microbiota and fecal levels of short-chain fatty acids differ upon 24-hour blood pressure levels in men. Hypertension 74, 1005–1013 (2019).
pubmed: 31352822
Wang, Y. et al. Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut. Gut Microbes 10, 367–381 (2018).
pubmed: 30359203
pmcid: 6546330
Hu, C. et al. A comprehensive analysis of the colonic flora diversity, short chain fatty acid metabolism, transcripts, and biochemical indexes in heat-stressed pigs. Front. Immunol. 12, 1 (2021).
Amiri, P. et al. Role of butyrate, a gut microbiota derived metabolite, in cardiovascular diseases: A comprehensive narrative review. Front. Pharmacol. 12, 1 (2022).
Eeckhaut, V. et al. Butyricicoccus pullicaecorum gen. nov., sp. nov., an anaerobic, butyrate-producing bacterium isolated from the caecal content of a broiler chicken. Int. J. Syst. Evol. Microbiol. 58, 2799–2802 (2008).
Nogal, A. et al. Circulating levels of the short-chain fatty acid acetate mediate the effect of the gut microbiome on visceral fat. Front. Microbiol. 12, (2021).
Abdugheni, R. et al. Metabolite profiling of human-originated Lachnospiraceae at the strain level. iMeta 1, e58 (2022).
Hiippala, K. et al. Novel odoribacter splanchnicus strain and its outer membrane vesicles exert immunoregulatory effects in vitro. Front. Microbiol. 11, 1 (2020).
Werner, H., Rintelen, G. & Kunstek-Santos, H. A new butyric acid-producing bacteroides species: B. splanchnicus n. sp. (author’s transl). Zentralbl Bakteriol Orig A 231, 133–144 (1975).
Parker, B. J., Wearsch, P. A., Veloo, A. C. M. & Rodriguez-Palacios, A. The genus alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health. Front. Immunol. 11, (2020).
Wallen, Z. D. Comparison study of differential abundance testing methods using two large Parkinson disease gut microbiome datasets derived from 16S amplicon sequencing. BMC Bioinf. 22, 265 (2021).
Calgaro, M., Romualdi, C., Waldron, L., Risso, D. & Vitulo, N. Assessment of statistical methods from single cell, bulk RNA-seq, and metagenomics applied to microbiome data. Genome Biol. 21, 191 (2020).
pubmed: 32746888
pmcid: 7398076
Cho, H. et al. Comprehensive evaluation of methods for differential expression analysis of metatranscriptomics data. Brief. Bioinf. 24, bbad279 (2023).
Fernandes, A. D., Macklaim, J. M., Linn, T. G., Reid, G. & Gloor, G. B. ANOVA-like differential expression (ALDEx) analysis for mixed population RNA-Seq. PLOS ONE 8, e67019 (2013).
pubmed: 23843979
pmcid: 3699591
Lin, H. & Peddada, S. D. Analysis of compositions of microbiomes with bias correction. Nat. Commun. 11, 3514 (2020).
pubmed: 32665548
pmcid: 7360769
Sohn, J. et al. Periodontal disease is associated with increased gut colonization of pathogenic Haemophilus parainfluenzae in patients with Crohn’s disease. Cell Rep. 42, 112120 (2023).
pubmed: 36774550
pmcid: 10415533
Fitzgerald, R. S., Sanderson, I. R. & Claesson, M. J. Paediatric inflammatory bowel disease and its relationship with the microbiome. Microb. Ecol. 82, 833–844 (2021).
pubmed: 33666710
pmcid: 8551107
Chen, J. et al. Gut microbiome alterations in patients with carotid atherosclerosis. Front. Cardiovasc. Med. 8, 1 (2021).
Palmnäs-Bédard, M. S. A. et al. The human gut microbiota and glucose metabolism: A scoping review of key bacteria and the potential role of SCFAs. Am. J. Clin. Nutr. 116, 862–874 (2022).
pubmed: 36026526
pmcid: 9535511
Makki, K., Deehan, E. C., Walter, J. & Bäckhed, F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe 23, 705–715 (2018).
pubmed: 29902436
Atzeni, A. et al. Taxonomic and functional fecal microbiota signatures associated with insulin resistance in non-diabetic subjects with overweight/obesity within the frame of the PREDIMED-plus study. Front. Endocrinol. (Lausanne) 13, 804455 (2022).
Roelofsen, H., Priebe, M. G. & Vonk, R. J. The interaction of short-chain fatty acids with adipose tissue: Relevance for prevention of type 2 diabetes. Benef. Microbes 1, 433–437 (2010).
pubmed: 21831781
Li, Y. et al. Effects of Konjaku flour on the gut microbiota of obese patients. Front. Cell. Infect. Microbiol. 12 (2022).
Singh, H. et al. Gastro-intestinal and oral microbiome signatures associated with healthy aging. GeroScience 41, 907–921 (2019).
pubmed: 31620923
pmcid: 6925087
Wu, X. & Park, S. Fecal bacterial community and metagenome function in Asians with type 2 diabetes according to enterotypes. Biomedicines 10, 2998 (2022).
pubmed: 36428566
pmcid: 9687834
Zeevi, D. et al. Structural variation in the gut microbiome associates with host health. Nature 568, 43–48 (2019).
pubmed: 30918406
Thingholm, L. B. et al. Obese individuals with and without Type 2 diabetes show different gut microbial functional capacity and composition. Cell Host Microbe 26, 252-264.e10 (2019).
pubmed: 31399369
pmcid: 7720933
Langenberg, C. & Lotta, L. A. Genomic insights into the causes of type 2 diabetes. Lancet 391, 2463–2474 (2018).
pubmed: 29916387
Sirdah, M. M. & Reading, N. S. Genetic predisposition in type 2 diabetes: A promising approach toward a personalized management of diabetes. Clin. Genet. 98, 525–547 (2020).
pubmed: 32385895
Stronks, K. et al. Unravelling the impact of ethnicity on health in Europe: The HELIUS study. BMC Public Health 13, 402 (2013).
pubmed: 23621920
pmcid: 3646682
Shojima, N. & Yamauchi, T. Progress in genetics of type 2 diabetes and diabetic complications. J. Diabetes Investig. 14, 503–515 (2023).
pubmed: 36639962
pmcid: 10034958
Stephenson, E. J., Smiles, W. & Hawley, J. A. The relationship between exercise, nutrition and type 2 diabetes. Med. Sport Sci. 60, 1–10 (2014).
pubmed: 25226796
Delpino, F. M. et al. Ultra-processed food and risk of type 2 diabetes: A systematic review and meta-analysis of longitudinal studies. Int. J. Epidemiol. 51, 1120–1141 (2022).
pubmed: 34904160
Canedo, J. R., Miller, S. T., Schlundt, D., Fadden, M. K. & Sanderson, M. Racial/ethnic disparities in diabetes quality of care: The role of healthcare access and socioeconomic status. J. Racial Ethn. Health Disparities 5, 7–14 (2018).
pubmed: 28078660
Espelt, A. et al. Socioeconomic position and type 2 diabetes mellitus in Europe 1999–2009: A panorama of inequalities. Curr. Diabetes Rev. 7, 148–158 (2011).
pubmed: 21418003
Custer, G. F., Gans, M., van Diepen, L. T. A., Dini-Andreote, F. & Buerkle, C. A. Comparative analysis of core microbiome assignments: Implications for ecological synthesis. mSystems 8, e01066–22 (2023).